What the Trump budget doesn’t do to address rising drug prices

President Donald Trump listens during a meeting with lawmakers about trade policy in the Cabinet Room of the White House, Tuesday, Feb. 13, 2018, in Washington. (AP Photo/Evan Vucci)

LA Times consumer columnist David Lazarus had high hopes for a budget plan that would prioritize addressing ludicrous drug prices.

Unfortunately, he was deeply disappointed to find that Trump’s self-proclaimed commitment to fight the corrupt practices of Big Pharma was not evident in the $4.4 trillion budget plan released Monday.

He joined host Ethan Bearman to explain why what the plan did provide to lower drug prices only serves a bandaid to a problem that needs a full-blown surgical operation.

Listen to the full segment below to hear his and Bearman’s conversation.


KGO Events